Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells

BACKGROUND: Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. METHODS: IL-12 levels were measured by E...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Bingyu, Qi, Jingjing, Yao, Genhong, Feng, Ruihai, Zhang, Zhuoya, Wang, Dandan, Chen, Chen, Tang, Xiaojun, Lu, Liwei, Chen, Wanjun, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225717/
https://www.ncbi.nlm.nih.gov/pubmed/30409219
http://dx.doi.org/10.1186/s13287-018-1023-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225717/
https://www.ncbi.nlm.nih.gov/pubmed/30409219
http://dx.doi.org/10.1186/s13287-018-1023-x

Ejemplares similares